{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:10:19Z","timestamp":1758399019734,"version":"3.37.3"},"reference-count":121,"publisher":"Bentham Science Publishers Ltd.","issue":"45","funder":[{"DOI":"10.13039\/501100005851","name":"research council of the School of Pharmacy, Shahid Beheshti University of Medical Sciences, Iran","doi-asserted-by":"publisher","award":["43002969"],"award-info":[{"award-number":["43002969"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n<jats:title>Abstracts:<\/jats:title>\n<jats:p>The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory\nsyndrome coronavirus 2 (SARS-CoV-2) became a major public health threat to all countries worldwide.\nSARS-CoV-2 interactions with its receptor are the first step in the invasion of the host cell. The coronavirus\nspike protein (S) is crucial in binding to receptors on host cells. Additionally, targeting the SARS-CoV-2 viral\nreceptors is considered a therapeutic option in this regard. In this review of literature, we summarized five potential\nhost cell receptors, as host-cell surface bindings, including angiotensin-converting enzyme 2 (ACE2),\nneuropilin 1 (NRP-1), dipeptidyl peptidase 4 (DPP4), glucose regulated protein-78 (GRP78), and cluster of differentiation\n147 (CD147) related to the SARS-CoV-2 infection. Among these targets, ACE2 was recognized as\nthe main SARS-CoV-2 receptor, expressed at a low\/moderate level in the human respiratory system, which is also\ninvolved in SARS-CoV-2 entrance, so the virus may utilize other secondary receptors. Besides ACE2,\nCD147 was discovered as a novel SARS-CoV-2 receptor, CD147 appears to be an alternate receptor for SARSCoV-\n2 infection. NRP-1, as a single-transmembrane glycoprotein, has been recently found to operate as an entrance\nfactor and enhance SARS Coronavirus 2 (SARS-CoV-2) infection under in-vitro. DPP4, which was discovered\nas the first gene clustered with ACE2, may serve as a potential SARS-CoV-2 spike protein binding target.\nGRP78 could be recognized as a secondary receptor for SARS-CoV-2 because it is widely expressed at substantially\ngreater levels, rather than ACE2, in bronchial epithelial cells and the respiratory mucosa. This review\nhighlights recent literature on this topic.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612829666221123111849","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T12:01:17Z","timestamp":1669291277000},"page":"3583-3591","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Host-Cell Surface Binding Targets in SARS-CoV-2 for Drug Design"],"prefix":"10.2174","volume":"28","author":[{"given":"Sayyed Abbas","family":"Tabatabai","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanieh","family":"Maleksabet","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Rezaee","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0140-6736(20)30673-5","volume":"395","author":"Bedford J.","year":"2020","unstructured":"Bedford J.; Enria D.; Giesecke J.; Heymann D.L.; Ihekweazu C.; Kobinger G.; Lane H.C.; Memish Z.; Oh M.; Sall A.A.; Schuchat A.; Ungchusak K.; Wieler L.H.; COVID-19: towards controlling of a pandemic. Lancet 2020,395(10229),1015-1018","journal-title":"Lancet"},{"year":"2020","key":"ref=2","unstructured":"WHO Middle East Respir Syndr coronavirus (MERS-CoV) WHO. 2020"},{"year":"2020","key":"ref=3","unstructured":"WHO SARS (Severe Acute Respir Syndr WHO. 2020"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","volume":"17","author":"Cui J.","year":"2019","unstructured":"Cui J.; Li F.; Shi Z.L.; Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019,17(3),181-192","journal-title":"Nat Rev Microbiol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/v11010059","volume":"11","author":"Song Z.","year":"2019","unstructured":"Song Z.; Xu Y.; Bao L.; Zhang L.; Yu P.; Qu Y.; Zhu H.; Zhao W.; Han Y.; Qin C.; From SARS to MERS, Thrusting Coronaviruses into the spotlight. Viruses 2019,11(1),59","journal-title":"Viruses"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/cr.2013.92","volume":"23","author":"Wang N.","year":"2013","unstructured":"Wang N.; Shi X.; Jiang L.; Zhang S.; Wang D.; Tong P.; Guo D.; Fu L.; Cui Y.; Liu X.; Arledge K.C.; Chen Y.H.; Zhang L.; Wang X.; Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res 2013,23(8),986-993","journal-title":"Cell Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"Hoffmann M.","year":"2020","unstructured":"Hoffmann M.; Kleine-Weber H.; Schroeder S.; Kr&#xFC;ger N.; Herrler T.; Erichsen S.; Schiergens T.S.; Herrler G.; Wu N.H.; Nitsche A.; M&#xFC;ller M.A.; Drosten C.; P&#xF6;hlmann S.; SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020,181(2),271-280.e8","journal-title":"Cell"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1745-6150-9-5","volume":"9","author":"Zhou H.","year":"2014","unstructured":"Zhou H.; Gao S.; Nguyen N.N.; Fan M.; Jin J.; Liu B.; Zhao L.; Xiong G.; Tan M.; Li S.; Wong L.; Stringent homology-based prediction of H. sapiens-M. tuberculosis H37Rv protein-protein interactions. Biol Direct 2014,9(1),5","journal-title":"Biol Direct"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","volume":"5","author":"Letko M.","year":"2020","unstructured":"Letko M.; Marzi A.; Munster V.; Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol 2020,5(4),562-569","journal-title":"Nat Microbiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"Zhou P.","year":"2020","unstructured":"Zhou P.; Yang X.L.; Wang X.G.; Hu B.; Zhang L.; Zhang W.; Si H.R.; Zhu Y.; Li B.; Huang C.L.; Chen H.D.; Chen J.; Luo Y.; Guo H.; Jiang R.D.; Liu M.Q.; Chen Y.; Shen X.R.; Wang X.; Zheng X.S.; Zhao K.; Chen Q.J.; Deng F.; Liu L.L.; Yan B.; Zhan F.X.; Wang Y.Y.; Xiao G.F.; Shi Z.L.; A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020,579(7798),270-273","journal-title":"Nature"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"9114","DOI":"10.1128\/JVI.01133-16","volume":"90","author":"Chan C.M.","year":"2016","unstructured":"Chan C.M.; Chu H.; Wang Y.; Wong B.H.Y.; Zhao X.; Zhou J.; Yang D.; Leung S.P.; Chan J.F.W.; Yeung M.L.; Yan J.; Lu G.; Gao G.F.; Yuen K.Y.; Carcinoembryonic antigen-related cell adhesion molecule 5 is an important surface attachment factor that facilitates entry of middle east respiratory syndrome coronavirus. J Virol 2016,90(20),9114-9127","journal-title":"J Virol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","volume":"41","author":"Huang Y.","year":"2020","unstructured":"Huang Y.; Yang C.; Xu X.; Xu W.; Liu S.; Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin 2020,41(9),1141-1149","journal-title":"Acta Pharmacol Sin"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.3892\/mmr.2020.11510","volume":"22","author":"Davies J.","year":"2020","unstructured":"Davies J.; Randeva H.; Chatha K.; Hall M.; Spandidos D.; Karteris E.; Kyrou I.; Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19. Mol Med Rep 2020,22(5),4221-4226","journal-title":"Mol Med Rep"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"e61390","DOI":"10.7554\/eLife.61390","volume":"9","author":"Zamorano Cuervo N.","year":"2020","unstructured":"Zamorano Cuervo N.; Grandvaux N.; ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities. eLife 2020,9,e61390","journal-title":"eLife"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","volume":"126","author":"Gheblawi M.","year":"2020","unstructured":"Gheblawi M.; Wang K.; Viveiros A.; Nguyen Q.; Zhong J.C.; Turner A.J.; Raizada M.K.; Grant M.B.; Oudit G.Y.; Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system. Circ Res 2020,126(10),1456-1474","journal-title":"Circ Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","volume":"46","author":"Zhang H.","year":"2020","unstructured":"Zhang H.; Penninger J.M.; Li Y.; Zhong N.; Slutsky A.S.; Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 2020,46(4),586-590","journal-title":"Intensive Care Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1254\/jphs.CPJ06008X","volume":"100","author":"Miyazaki M.","year":"2006","unstructured":"Miyazaki M.; Takai S.; Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase. J Pharmacol Sci 2006,100(5),391-397","journal-title":"J Pharmacol Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1002\/cmdc.202000368","volume":"15","author":"Gross L.Z.F.","year":"2020","unstructured":"Gross L.Z.F.; Sacerdoti M.; Piiper A.; Zeuzem S.; Leroux A.E.; Biondi R.M.; ACE2, the receptor that enables infection by SARS-CoV-2: Biochemistry, structure, allostery and evaluation of the potential development of ACE2 modulators. ChemMedChem 2020,15(18),1682-1690","journal-title":"ChemMedChem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1253\/circj.CJ-12-1544","volume":"77","author":"Kuba K.","year":"2013","unstructured":"Kuba K.; Imai Y.; Penninger J.M.; Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases. Circ J 2013,77(2),301-308","journal-title":"Circ J"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","volume":"118","author":"Patel V.B.","year":"2016","unstructured":"Patel V.B.; Zhong J.C.; Grant M.B.; Oudit G.Y.; Role of the ACE2\/angiotensin 1\u20137 axis of the renin\u2013angiotensin system in heart failure. Circ Res 2016,118(8),1313-1326","journal-title":"Circ Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.tips.2004.04.001","volume":"25","author":"Turner A.J.","year":"2004","unstructured":"Turner A.J.; Hiscox J.A.; Hooper N.M.; ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci 2004,25(6),291-294","journal-title":"Trends Pharmacol Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"Kuba K.","year":"2005","unstructured":"Kuba K.; Imai Y.; Rao S.; Gao H.; Guo F.; Guan B.; Huan Y.; Yang P.; Zhang Y.; Deng W.; Bao L.; Zhang B.; Liu G.; Wang Z.; Chappell M.; Liu Y.; Zheng D.; Leibbrandt A.; Wada T.; Slutsky A.S.; Liu D.; Qin C.; Jiang C.; Penninger J.M.; A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury. Nat Med 2005,11(8),875-879","journal-title":"Nat Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"33238","DOI":"10.1074\/jbc.M002615200","volume":"275","author":"Tipnis S.R.","year":"2000","unstructured":"Tipnis S.R.; Hooper N.M.; Hyde R.; Karran E.; Christie G.; Turner A.J.; A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000,275(43),33238-33243","journal-title":"J Biol Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1161\/HYPERTENSIONAHA.107.100693","volume":"51","author":"Der Sarkissian S.","year":"2008","unstructured":"Der Sarkissian S.; Grobe J.L.; Yuan L.; Narielwala D.R.; Walter G.A.; Katovich M.J.; Raizada M.K.; Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology. Hypertension 2008,51(3),712-718","journal-title":"Hypertension"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2353\/ajpath.2007.060977","volume":"171","author":"Wong D.W.","year":"2007","unstructured":"Wong D.W.; Oudit G.Y.; Reich H.; Kassiri Z.; Zhou J.; Liu Q.C.; Backx P.H.; Penninger J.M.; Herzenberg A.M.; Scholey J.W.; Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 2007,171(2),438-451","journal-title":"Am J Pathol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/HYPERTENSIONAHA.108.114322","volume":"52","author":"Rentzsch B.","year":"2008","unstructured":"Rentzsch B.; Todiras M.; Iliescu R.; Popova E.; Campos L.A.; Oliveira M.L.; Baltatu O.C.; Santos R.A.; Bader M.; Transgenic angiotensin- converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. Hypertension 2008,52(5),967-973","journal-title":"Hypertension"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.06.003","volume":"128","author":"Kuba K.","year":"2010","unstructured":"Kuba K.; Imai Y.; Ohto-Nakanishi T.; Penninger J.M.; Trilogy of ACE2: A peptidase in the renin\u2013angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol Ther 2010,128(1),119-128","journal-title":"Pharmacol Ther"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","volume":"76","author":"Verdecchia P.","year":"2020","unstructured":"Verdecchia P.; Cavallini C.; Spanevello A.; Angeli F.; The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med 2020,76,14-20","journal-title":"Eur J Intern Med"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","volume":"9","author":"Meng J.","year":"2020","unstructured":"Meng J.; Xiao G.; Zhang J.; He X.; Ou M.; Bi J.; Yang R.; Di W.; Wang Z.; Li Z.; Gao H.; Liu L.; Zhang G.; Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect 2020,9(1),757-760","journal-title":"Emerg Microbes Infect"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","volume":"126","author":"Zhang P.","year":"2020","unstructured":"Zhang P.; Zhu L.; Cai J.; Lei F.; Qin J.J.; Xie J.; Liu Y.M.; Zhao Y.C.; Huang X.; Lin L.; Xia M.; Chen M.M.; Cheng X.; Zhang X.; Guo D.; Peng Y.; Ji Y.X.; Chen J.; She Z.G.; Wang Y.; Xu Q.; Tan R.; Wang H.; Lin J.; Luo P.; Fu S.; Cai H.; Ye P.; Xiao B.; Mao W.; Liu L.; Yan Y.; Liu M.; Chen M.; Zhang X.J.; Wang X.; Touyz R.M.; Xia J.; Zhang B.H.; Huang X.; Yuan Y.; Loomba R.; Liu P.P.; Li H.; Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res 2020,126(12),1671-1681","journal-title":"Circ Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41574-020-0353-9","volume":"16","author":"Bornstein S.R.","year":"2020","unstructured":"Bornstein S.R.; Dalan R.; Hopkins D.; Mingrone G.; Boehm B.O.; Endocrine and metabolic link to coronavirus infection. Nat Rev Endocrinol 2020,16(6),297-298","journal-title":"Nat Rev Endocrinol"},{"key":"ref=32","author":"Khera R.","year":"2021","unstructured":"Khera R.; Clark C.; Lu Y.; Guo Y.; Ren S.; Truax B.; Association of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers with the risk of hospitalization and death in hypertensive patients with coronavirus disease-19. J Am Heart Assoc 2021","journal-title":"J Am Heart Assoc"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/ddr.21656","volume":"81","author":"Gurwitz D.","year":"2020","unstructured":"Gurwitz D.; Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev Res 2020,81(5),537-540","journal-title":"Drug Dev Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jacc.2020.06.003","volume":"76","author":"Bloch M.J.","year":"2020","unstructured":"Bloch M.J.; Renin-angiotensin system blockade in COVID-19. J Am Coll Cardiol 2020,76(3),277-279","journal-title":"J Am Coll Cardiol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","volume":"382","author":"Vaduganathan M.","year":"2020","unstructured":"Vaduganathan M.; Vardeny O.; Michel T.; McMurray J.J.V.; Pfeffer M.A.; Solomon S.D.; Renin\u2013angiotensin\u2013aldosterone system inhibitors in patients with COVID-19. N Engl J Med 2020,382(17),1653-1659","journal-title":"N Engl J Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1093\/cvr\/cvaa097","volume":"116","author":"Kreutz R.","year":"2020","unstructured":"Kreutz R.; Algharably E.A.E.H.; Azizi M.; Dobrowolski P.; Guzik T.; Januszewicz A.; Persu A.; Prejbisz A.; Riemer T.G.; Wang J.G.; Burnier M.; Hypertension, the renin\u2013angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19. Cardiovasc Res 2020,116(10),1688-1699","journal-title":"Cardiovasc Res"},{"key":"ref=37","first-page":"85","volume":"133","author":"Talreja H.","year":"2020","unstructured":"Talreja H.; Tan J.; Dawes M.; Supershad S.; Rabindranath K.; Fisher J.; Valappil S.; van der Merwe V.; Wong L.; van der Merwe W.; Paton J.; A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019). N Z Med J 2020,133(1512),85-87","journal-title":"N Z Med J"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1089\/met.2020.0037","volume":"18","author":"Stoian A.P.","year":"2020","unstructured":"Stoian A.P.; Banerjee Y.; Rizvi A.A.; Rizzo M.; Diabetes and the COVID-19 pandemic: How insights from recent experience might guide Future management. Metab Syndr Relat Disord 2020,18(4),173-175","journal-title":"Metab Syndr Relat Disord"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"E736","DOI":"10.1152\/ajpendo.00124.2020","volume":"318","author":"Muniyappa R.","year":"2020","unstructured":"Muniyappa R.; Gubbi S.; COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Endocrinol Metab 2020,318(5),E736-E741","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.abc0870","volume":"369","author":"Chan K.K.","year":"2020","unstructured":"Chan K.K.; Dorosky D.; Sharma P.; Abbasi S.A.; Dye J.M.; Kranz D.M.; Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2. Science 2020,369(6508),1261-5","journal-title":"Science"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","volume":"181","author":"Monteil V.","year":"2020","unstructured":"Monteil V.; Kwon H.; Prado P.; Hagelkr&#xFC;ys A.; Wimmer R.A.; Stahl M.; Leopoldi A.; Garreta E.; Hurtado del Pozo C.; Prosper F.; Romero J.P.; Wirnsberger G.; Zhang H.; Slutsky A.S.; Conder R.; Montserrat N.; Mirazimi A.; Penninger J.M.; Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 2020,181(4),905-913.e7","journal-title":"Cell"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1042\/CS20200163","volume":"134","author":"Batlle D.","year":"2020","unstructured":"Batlle D.; Wysocki J.; Satchell K.; Soluble angiotensin-converting enzyme 2: A potential approach for coronavirus infection therapy? Clin Sci (Lond) 2020,134(5),543-545","journal-title":"Clin Sci (Lond)"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1126\/science.1116480","volume":"309","author":"Li F.","year":"2005","unstructured":"Li F.; Coronavirus spike receptor-binding domain complexed with receptor. Science 2005,309(5742),1864-8","journal-title":"Science"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"Li W.","year":"2003","unstructured":"Li W.; Moore M.J.; Vasilieva N.; Sui J.; Wong S.K.; Berne M.A.; Somasundaran M.; Sullivan J.L.; Luzuriaga K.; Greenough T.C.; Choe H.; Farzan M.; Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003,426(6965),450-454","journal-title":"Nature"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Imai Y.","year":"2005","unstructured":"Imai Y.; Kuba K.; Rao S.; Huan Y.; Guo F.; Guan B.; Yang P.; Sarao R.; Wada T.; Leong-Poi H.; Crackower M.A.; Fukamizu A.; Hui C.C.; Hein L.; Uhlig S.; Slutsky A.S.; Jiang C.; Penninger J.M.; Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005,436(7047),112-116","journal-title":"Nature"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1164\/rccm.201412-2326OC","volume":"192","author":"Zhang R.","year":"2015","unstructured":"Zhang R.; Pan Y.; Fanelli V.; Wu S.; Luo A.A.; Islam D.; Han B.; Mao P.; Ghazarian M.; Zeng W.; Spieth P.M.; Wang D.; Khang J.; Mo H.; Liu X.; Uhlig S.; Liu M.; Laffey J.; Slutsky A.S.; Li Y.; Zhang H.; Mechanical stress and the induction of lung fibrosis via the midkine signaling pathway. Am J Respir Crit Care Med 2015,192(3),315-323","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/path.2987","volume":"225","author":"W&#xF6;sten-van Asperen R.M.","year":"2011","unstructured":"W&#xF6;sten-van Asperen R.M.; Lutter R.; Specht P.A.; Moll G.N.; van Woensel J.B.; van der Loos C.M.; van Goor H.; Kamilic J.; Florquin S.; Bos A.P.; Acute respiratory distress syndrome leads to reduced ratio of ACE\/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist. J Pathol 2011,225(4),618-627","journal-title":"J Pathol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"e13426","DOI":"10.15252\/emmm.202013426","volume":"13","author":"Monteil V.","year":"2021","unstructured":"Monteil V.; Dyczynski M.; Lauschke V.M.; Kwon H.; Wirnsberger G.; Youhanna S.; Zhang H.; Slutsky A.S.; Hurtado del Pozo C.; Horn M.; Montserrat N.; Penninger J.M.; Mirazimi A.; Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 infection. EMBO Mol Med 2021,13(1),e13426","journal-title":"EMBO Mol Med"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","volume":"21","author":"Khan A.","year":"2017","unstructured":"Khan A.; Benthin C.; Zeno B.; Albertson T.E.; Boyd J.; Christie J.D.; Hall R.; Poirier G.; Ronco J.J.; Tidswell M.; Hardes K.; Powley W.M.; Wright T.J.; Siederer S.K.; Fairman D.A.; Lipson D.A.; Bayliffe A.I.; Lazaar A.L.; A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Crit Care 2017,21(1),234","journal-title":"Crit Care"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s40262-013-0072-7","volume":"52","author":"Haschke M.","year":"2013","unstructured":"Haschke M.; Schuster M.; Poglitsch M.; Loibner H.; Salzberg M.; Bruggisser M.; Penninger J.; Kr&#xE4;henb&#xFC;hl S.; Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects. Clin Pharmacokinet 2013,52(9),783-792","journal-title":"Clin Pharmacokinet"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","volume":"5","author":"Wang K.","year":"2020","unstructured":"Wang K.; Chen W.; Zhang Z.; Deng Y.; Lian J.Q.; Du P.; Wei D.; Zhang Y.; Sun X.X.; Gong L.; Yang X.; He L.; Zhang L.; Yang Z.; Geng J.J.; Chen R.; Zhang H.; Wang B.; Zhu Y.M.; Nan G.; Jiang J.L.; Li L.; Wu J.; Lin P.; Huang W.; Xie L.; Zheng Z.H.; Zhang K.; Miao J.L.; Cui H.Y.; Huang M.; Zhang J.; Fu L.; Yang X.M.; Zhao Z.; Sun S.; Gu H.; Wang Z.; Wang C.F.; Lu Y.; Liu Y.Y.; Wang Q.Y.; Bian H.; Zhu P.; Chen Z.N.; CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther 2020,5(1),283","journal-title":"Signal Transduct Target Ther"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/path.5054","volume":"245","author":"Cui J.","year":"2018","unstructured":"Cui J.; Huang W.; Wu B.; Jin J.; Jing L.; Shi W.P.; Liu Z.Y.; Yuan L.; Luo D.; Li L.; Chen Z.N.; Jiang J.L.; N-glycosylation by N-acetylglucosaminyltransferase V enhances the interaction of CD147\/basigin with integrin &#x3B2;1 and promotes HCC metastasis. J Pathol 2018,245(1),41-52","journal-title":"J Pathol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"9052","DOI":"10.1128\/JVI.77.16.9052-9068.2003","volume":"77","author":"Castro A.P.V.","year":"2003","unstructured":"Castro A.P.V.; Carvalho T.M.U.; Moussatch&#xE9; N.; Damaso C.R.A.; Redistribution of cyclophilin A to viral factories during vaccinia virus infection and its incorporation into mature particles. J Virol 2003,77(16),9052-9068","journal-title":"J Virol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jhep.2014.04.035","volume":"61","author":"Huang Q.","year":"2014","unstructured":"Huang Q.; Li J.; Xing J.; Li W.; Li H.; Ke X.; Zhang J.; Ren T.; Shang Y.; Yang H.; Jiang J.; Chen Z.; CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway. J Hepatol 2014,61(4),859-866","journal-title":"J Hepatol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1182\/blood-2017-08-802918","volume":"131","author":"Zhang M.Y.","year":"2018","unstructured":"Zhang M.Y.; Zhang Y.; Wu X.D.; Zhang K.; Lin P.; Bian H.J.; Qin M.M.; Huang W.; Wei D.; Zhang Z.; Wu J.; Chen R.; Feng F.; Wang B.; Nan G.; Zhu P.; Chen Z.N.; Disrupting CD147-RAP2 interaction abrogates erythrocyte invasion by Plasmodium falciparum. Blood 2018,131(10),1111-1121","journal-title":"Blood"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/hep.29798","volume":"68","author":"Lu M.","year":"2018","unstructured":"Lu M.; Wu J.; Hao Z.W.; Shang Y.K.; Xu J.; Nan G.; Li X.; Chen Z.N.; Bian H.; Basolateral CD147 induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation in hepatocellular carcinoma progress. Hepatology 2018,68(1),317-332","journal-title":"Hepatology"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1002\/hep.24592","volume":"54","author":"Zhao P.","year":"2011","unstructured":"Zhao P.; Zhang W.; Wang S.J.; Yu X.L.; Tang J.; Huang W.; Li Y.; Cui H.Y.; Guo Y.S.; Tavernier J.; Zhang S.H.; Jiang J.L.; Chen Z.N.; HAb18G\/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells. Hepatology 2011,54(6),2012-2024","journal-title":"Hepatology"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.yexmp.2018.05.001","volume":"104","author":"Su H.","year":"2018","unstructured":"Su H.; Yang Y.; The roles of CyPA and CD147 in cardiac remodelling. Exp Mol Pathol 2018,104(3),222-226","journal-title":"Exp Mol Pathol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/ndt\/gfu302","volume":"30","author":"Kosugi T.","year":"2015","unstructured":"Kosugi T.; Maeda K.; Sato W.; Maruyama S.; Kadomatsu K.; CD147 (EMMPRIN\/Basigin) in kidney diseases: from an inflammation and immune system viewpoint. Nephrol Dial Transplant 2015,30(7),1097-1103","journal-title":"Nephrol Dial Transplant"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1086\/427811","volume":"191","author":"Chen Z.","year":"2005","unstructured":"Chen Z.; Mi L.; Xu J.; Yu J.; Wang X.; Jiang J.; Xing J.; Shang P.; Qian A.; Li Y.; Shaw P.X.; Wang J.; Duan S.; Ding J.; Fan C.; Zhang Y.; Yang Y.; Yu X.; Feng Q.; Li B.; Yao X.; Zhang Z.; Li L.; Xue X.; Zhu P.; Function of HAb18G\/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus. J Infect Dis 2005,191(5),755-760","journal-title":"J Infect Dis"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s12015-020-09976-7","volume":"16","author":"Ulrich H.","year":"2020","unstructured":"Ulrich H.; Pillat M.M.; CD147 as a target for COVID-19 treatment: Suggested effects of azithromycin and stem cell engagement. Stem Cell Rev Rep 2020,16(3),434-440","journal-title":"Stem Cell Rev Rep"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00109-015-1334-7","volume":"94","author":"Zhai Y.","year":"2016","unstructured":"Zhai Y.; Wu B.; Li J.; Yao X.; Zhu P.; Chen Z.; CD147 promotes IKK\/I&#x3BA;B\/NF-&#x3BA;B pathway to resist TNF-induced apoptosis in rheumatoid arthritis synovial fibroblasts. J Mol Med (Berl) 2016,94(1),71-82","journal-title":"J Mol Med (Berl)"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11010-016-2808-9","volume":"422","author":"Su H.","year":"2016","unstructured":"Su H.; Li J.; Chen T.; Li N.; Xiao J.; Wang S.; Guo X.; Yang Y.; Bu P.; Melatonin attenuates angiotensin II-induced cardiomyocyte hypertrophy through the CyPA\/CD147 signaling pathway. Mol Cell Biochem 2016,422(1-2),85-95","journal-title":"Mol Cell Biochem"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3390\/cells8091041","volume":"8","author":"de Farias T da SM.","year":"2019","unstructured":"de Farias T da SM.; Melatonin supplementation attenuates the pro-inflammatory adipokines expression in visceral fat from obese mice induced by a high-fat diet. Cells 2019,8(9),1041","journal-title":"Cells"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"100056","DOI":"10.1016\/j.medidd.2020.100056","volume":"7","author":"Liu C.","year":"2020","unstructured":"Liu C.; von Brunn A.; Zhu D.; Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19. Med Drug Discov 2020,7,100056","journal-title":"Med Drug Discov"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/09273948.2020.1772314","volume":"28","author":"Leonardi A.","year":"2020","unstructured":"Leonardi A.; Rosani U.; Brun P.; Ocular surface expression of SARS-CoV-2 receptors. Ocul Immunol Inflamm 2020,28(5),735-738","journal-title":"Ocul Immunol Inflamm"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"2001123","DOI":"10.1183\/13993003.01123-2020","volume":"56","author":"Aguiar J.A.","year":"2020","unstructured":"Aguiar J.A.; Tremblay B.J.M.; Mansfield M.J.; Woody O.; Lobb B.; Banerjee A.; Chandiramohan A.; Tiessen N.; Cao Q.; Dvorkin-Gheva A.; Revill S.; Miller M.S.; Carlsten C.; Organ L.; Joseph C.; John A.; Hanson P.; Austin R.C.; McManus B.M.; Jenkins G.; Mossman K.; Ask K.; Doxey A.C.; Hirota J.A.; Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue. Eur Respir J 2020,56(3),2001123","journal-title":"Eur Respir J"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1111\/all.14429","volume":"75","author":"Radzikowska U.","year":"2020","unstructured":"Radzikowska U.; Ding M.; Tan G.; Zhakparov D.; Peng Y.; Wawrzyniak P.; Wang M.; Li S.; Morita H.; Altunbulakli C.; Reiger M.; Neumann A.U.; Lunjani N.; Traidl-Hoffmann C.; Nadeau K.C.; O\u2019Mahony L.; Akdis C.; Sokolowska M.; Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy 2020,75(11),2829-2845","journal-title":"Allergy"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.csbj.2021.03.025","volume":"19","author":"Jobe A.","year":"2021","unstructured":"Jobe A.; Vijayan R.; Neuropilins: C-end rule peptides and their association with nociception and COVID-19. Comput Struct Biotechnol J 2021,19,1889-1895","journal-title":"Comput Struct Biotechnol J"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.abd2985","volume":"370","author":"Cantuti-Castelvetri L.","year":"2020","unstructured":"Cantuti-Castelvetri L.; Ojha R.; Pedro L.D.; Djannatian M.; Franz J.; Kuivanen S.; Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science (80-) 2020,370(6518),856-60","journal-title":"Science (80-)"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1126\/science.abd3072","volume":"370","author":"Daly J.L.","year":"2020","unstructured":"Daly J.L.; Simonetti B.; Klein K.; Chen K-E.; Williamson M.K.; Ant&#xF3;n-Pl&#xE1;garo C.; Neuropilin-1 is a host factor for SARS-CoV- 2 infection. Science 2020,370(6518),861-5","journal-title":"Science"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.3390\/jcm10132772","volume":"10","author":"Gudowska-Sawczuk M.","year":"2021","unstructured":"Gudowska-Sawczuk M.; Mroczko B.; The role of neuropilin-1 (NRP-1) in SARS-CoV-2 infection. J Clin Med 2021,10(13),2772-2730","journal-title":"J Clin Med"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.3390\/cells9112343","volume":"9","author":"Papageorgiou A.C.","year":"2020","unstructured":"Papageorgiou A.C.; Mohsin I.; The SARS-CoV-2 spike glycoprotein as a drug and vaccine target: Structural insights into its complexes with ACE2 and antibodies. Cells 2020,9(11),2343","journal-title":"Cells"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"104742","DOI":"10.1016\/j.antiviral.2020.104742","volume":"176","author":"Coutard B.","year":"2020","unstructured":"Coutard B.; Valle C.; de Lamballerie X.; Canard B.; Seidah N.G.; Decroly E.; The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res 2020,176,104742","journal-title":"Antiviral Res"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"16157","DOI":"10.1073\/pnas.0908201106","volume":"106","author":"Teesalu T.","year":"2009","unstructured":"Teesalu T.; Sugahara K.N.; Kotamraju V.R.; Ruoslahti E.; C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc Natl Acad Sci USA 2009,106(38),16157-16162","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"e1009225","DOI":"10.1371\/journal.ppat.1009225","volume":"17","author":"Murgolo N.","year":"2021","unstructured":"Murgolo N.; Therien A.G.; Howell B.; Klein D.; Koeplinger K.; Lieberman L.A.; SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development. PLOS Pathog 2021,17(2),e1009225","journal-title":"PLOS Pathog"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1126\/science.abf0732","volume":"370","author":"Kielian M.","year":"2020","unstructured":"Kielian M.; Enhancing host cell infection by SARS-CoV-2. Science 2020,370(6518),765-6","journal-title":"Science"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/chemse\/bjx025","volume":"42","author":"Boesveldt S.","year":"2017","unstructured":"Boesveldt S.; Postma E.M.; Boak D.; Welge-Luessen A.; Sch&#xF6;pf V.; Mainland J.D.; Martens J.; Ngai J.; Duffy V.B.; Anosmia-A Clinical Review. Chem Senses 2017,42(7),513-523","journal-title":"Chem Senses"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"e106230","DOI":"10.15252\/embj.2020106230","volume":"39","author":"Ramani A.","year":"2020","unstructured":"Ramani A.; M&#xFC;ller L.; Ostermann P.N.; Gabriel E.; Abida-Islam P.; M&#xFC;ller-Schiffmann A.; Mariappan A.; Goureau O.; Gruell H.; Walker A.; Andr&#xE9;e M.; Hauka S.; Houwaart T.; Dilthey A.; Wohlgemuth K.; Omran H.; Klein F.; Wieczorek D.; Adams O.; Timm J.; Korth C.; Schaal H.; Gopalakrishnan J.; SARS-CoV-2 targets neurons of 3D human brain organoids. EMBO J 2020,39(20),e106230","journal-title":"EMBO J"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"e1009153","DOI":"10.1371\/journal.ppat.1009153","volume":"17","author":"Mayi B.S.","year":"2021","unstructured":"Mayi B.S.; Leibowitz J.A.; Woods A.T.; Ammon K.A.; Liu A.E.; Raja A.; The role of Neuropilin-1 in COVID-19. PLoS Pathog 2021,17(1),e1009153","journal-title":"PLoS Pathog"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbrc.2020.03.044","volume":"526","author":"Qi F.","year":"2020","unstructured":"Qi F.; Qian S.; Zhang S.; Zhang Z.; Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun 2020,526(1),135-140","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4103\/JOD.JOD_53_20","volume":"11","author":"Singh A.","year":"2020","unstructured":"Singh A.; Singh R.; Dipeptidyl-peptidase-4 inhibitors in type 2 diabetes and COVID-19: From a potential repurposed agent to a useful treatment option. Journal of Diabetology 2020,11(3),131","journal-title":"Journal of Diabetology"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"108216","DOI":"10.1016\/j.diabres.2020.108216","volume":"164","author":"Dalan R.","year":"2020","unstructured":"Dalan R.; Is DPP4 inhibition a comrade or adversary in COVID-19 infection. Diabetes Res Clin Pract 2020,164,108216","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.diabet.2020.05.008","volume":"46","author":"Scheen A.J.","year":"2020","unstructured":"Scheen A.J.; Marre M.; Thivolet C.; Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports. Diabetes Metab 2020,46(4),265-271","journal-title":"Diabetes Metab"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1177\/1074248420937868","volume":"25","author":"Stoian A.P.","year":"2020","unstructured":"Stoian A.P.; Papanas N.; Prazny M.; Rizvi A.A.; Rizzo M.; Incretin-based therapies role in COVID-19 era: Evolving insights. J Cardiovasc Pharmacol Ther 2020,25(6),494-496","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cei.12781","volume":"185","author":"Klemann C.","year":"2016","unstructured":"Klemann C.; Wagner L.; Stephan M.; von H&#xF6;rsten S.; Cut to the chase: a review of CD26\/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system. Clin Exp Immunol 2016,185(1),1-21","journal-title":"Clin Exp Immunol"},{"key":"ref=87","volume":"10","author":"Deacon C.F.","year":"2019","unstructured":"Deacon C.F.; Physiology and pharmacology of DPP-4 in glucose homeostasis and the treatment of type 2 diabetes. Front Endocrinol 2019,10","journal-title":"Front Endocrinol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1210\/er.2011-1052","volume":"33","author":"Ussher J.R.","year":"2012","unstructured":"Ussher J.R.; Drucker D.J.; Cardiovascular biology of the incretin system. Endocr Rev 2012,33(2),187-215","journal-title":"Endocr Rev"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrcardio.2012.183","volume":"10","author":"Scheen A.J.","year":"2013","unstructured":"Scheen A.J.; Cardiovascular effects of gliptins. Nat Rev Cardiol 2013,10(2),73-84","journal-title":"Nat Rev Cardiol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature12005","volume":"495","author":"Raj V.S.","year":"2013","unstructured":"Raj V.S.; Mou H.; Smits S.L.; Dekkers D.H.W.; M&#xFC;ller M.A.; Dijkman R.; Muth D.; Demmers J.A.A.; Zaki A.; Fouchier R.A.M.; Thiel V.; Drosten C.; Rottier P.J.M.; Osterhaus A.D.M.E.; Bosch B.J.; Haagmans B.L.; Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 2013,495(7440),251-254","journal-title":"Nature"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","volume":"9","author":"Vankadari N.","year":"2020","unstructured":"Vankadari N.; Wilce J.A.; Emerging COVID-19 coronavirus: Glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect 2020,9(1),601-604","journal-title":"Emerg Microbes Infect"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00592-018-1271-3","volume":"56","author":"Sesti G.","year":"2019","unstructured":"Sesti G.; Avogaro A.; Belcastro S.; Bonora B.M.; Croci M.; Daniele G.; Dauriz M.; Dotta F.; Formichi C.; Frontoni S.; Invitti C.; Orsi E.; Picconi F.; Resi V.; Bonora E.; Purrello F.; Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus. Acta Diabetol 2019,56(6),605-617","journal-title":"Acta Diabetol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/microorganisms9061211","volume":"9","author":"Norouzi M.","year":"2021","unstructured":"Norouzi M.; Norouzi S.; Ruggiero A.; Khan M.S.; Myers S.; Kavanagh K.; Vemuri R.; Type-2 diabetes as a risk factor for severe COVID-19 infection. Microorganisms 2021,9(6),1211","journal-title":"Microorganisms"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"101213","DOI":"10.1016\/j.diabet.2020.11.005","volume":"47","author":"Scheen A.J.","year":"2021","unstructured":"Scheen A.J.; DPP-4 inhibition and COVID-19: From initial concerns to recent expectations. Diabetes Metab 2021,47(2),101213","journal-title":"Diabetes Metab"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"Huang C.","year":"2020","unstructured":"Huang C.; Wang Y.; Li X.; Ren L.; Zhao J.; Hu Y.; Zhang L.; Fan G.; Xu J.; Gu X.; Cheng Z.; Yu T.; Xia J.; Wei Y.; Wu W.; Xie X.; Yin W.; Li H.; Liu M.; Xiao Y.; Gao H.; Guo L.; Xie J.; Wang G.; Jiang R.; Gao Z.; Jin Q.; Wang J.; Cao B.; Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020,395(10223),497-506","journal-title":"Lancet"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41577-020-0305-6","volume":"20","author":"Vaninov N.","year":"2020","unstructured":"Vaninov N.; In the eye of the COVID-19 cytokine storm. Nat Rev Immunol 2020,20(5),277","journal-title":"Nat Rev Immunol"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/2229-516X.198516","volume":"7","author":"Kagal U.A.","unstructured":"Kagal U.A.; Angadi N.B.; Matule S.M.; Effect of dipeptidyl peptidase 4 inhibitors on acute and subacute models of inflammation in male Wistar rats: An experimental study. Int J Appl basic Med Res ,7(1),26-31","journal-title":"Int J Appl basic Med Res"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"e000227","DOI":"10.1136\/bmjdrc-2016-000227","volume":"4","author":"Birnbaum Y.","year":"2016","unstructured":"Birnbaum Y.; Bajaj M.; Qian J.; Ye Y.; Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3\/ASC inflammasome. BMJ Open Diabetes Res Care 2016,4(1),e000227","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"110111","DOI":"10.1016\/j.mehy.2020.110111","volume":"143","author":"Mozafari N.","year":"2020","unstructured":"Mozafari N.; Azadi S.; Mehdi-Alamdarlou S.; Ashrafi H.; Azadi A.; Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin. Med Hypotheses 2020,143,110111","journal-title":"Med Hypotheses"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"10","DOI":"10.18502\/ijaai.v19i(s1.r1).2849","volume":"19","author":"Dastan F.","year":"2020","unstructured":"Dastan F.; Abedini A.; Shahabi S.; Kiani A.; Saffaei A.; Zare A.; Sitagliptin repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and inflammatory cytokine storms in the lung. Iran J Allergy Asthma Immunol 2020,19(S1),10-12","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s40618-021-01515-6","volume":"44","author":"Bonora B.M.","year":"2021","unstructured":"Bonora B.M.; Avogaro A.; Fadini G.P.; Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: Narrative review and meta-analysis. J Endocrinol Invest 2021,44(7),1379-1386","journal-title":"J Endocrinol Invest"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/med.21513","volume":"39","author":"Tomovic K.","year":"2019","unstructured":"Tomovic K.; Lazarevic J.; Kocic G.; Deljanin-Ilic M.; Anderluh M.; Smelcerovic A.; Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection. Med Res Rev 2019,39(1),404-422","journal-title":"Med Res Rev"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","volume":"31","author":"Zhu L.","year":"2020","unstructured":"Zhu L.; She Z.G.; Cheng X.; Qin J.J.; Zhang X.J.; Cai J.; Lei F.; Wang H.; Xie J.; Wang W.; Li H.; Zhang P.; Song X.; Chen X.; Xiang M.; Zhang C.; Bai L.; Xiang D.; Chen M.M.; Liu Y.; Yan Y.; Liu M.; Mao W.; Zou J.; Liu L.; Chen G.; Luo P.; Xiao B.; Zhang C.; Zhang Z.; Lu Z.; Wang J.; Lu H.; Xia X.; Wang D.; Liao X.; Peng G.; Ye P.; Yang J.; Yuan Y.; Huang X.; Guo J.; Zhang B.H.; Li H.; Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab 2020,31(6),1068-1077.e3","journal-title":"Cell Metab"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","volume":"13","author":"Fagerberg L.","year":"2014","unstructured":"Fagerberg L.; Hallstr&#xF6;m B.M.; Oksvold P.; Kampf C.; Djureinovic D.; Odeberg J.; Habuka M.; Tahmasebpoor S.; Danielsson A.; Edlund K.; Asplund A.; Sj&#xF6;stedt E.; Lundberg E.; Szigyarto C.A.K.; Skogs M.; Takanen J.O.; Berling H.; Tegel H.; Mulder J.; Nilsson P.; Schwenk J.M.; Lindskog C.; Danielsson F.; Mardinoglu A.; Sivertsson &#xC5;.; von Feilitzen K.; Forsberg M.; Zwahlen M.; Olsson I.; Navani S.; Huss M.; Nielsen J.; Ponten F.; Uhl&#xE9;n M.; Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics 2014,13(2),397-406","journal-title":"Mol Cell Proteomics"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2174\/156652406775574523","volume":"6","author":"Li J.","year":"2006","unstructured":"Li J.; Lee A.; Stress induction of GRP78\/BiP and its role in cancer. Curr Mol Med 2006,6(1),45-54","journal-title":"Curr Mol Med"},{"key":"ref=106","first-page":"1409","volume":"23","author":"Quinones Q.J.","year":"2008","unstructured":"Quinones Q.J.; de Ridder G.G.; Pizzo S.V.; GRP78: a chaperone with diverse roles beyond the endoplasmic reticulum. Histol Histopathol 2008,23(11),1409-1416","journal-title":"Histol Histopathol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ymeth.2004.10.010","volume":"35","author":"Lee A.S.","year":"2005","unstructured":"Lee A.S.; The ER chaperone and signaling regulator GRP78\/BiP as a monitor of endoplasmic reticulum stress. Methods 2005,35(4),373-381","journal-title":"Methods"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0014-5793(02)02289-5","volume":"514","author":"Rao R.V.","year":"2002","unstructured":"Rao R.V.; Peel A.; Logvinova A.; del Rio G.; Hermel E.; Yokota T.; Goldsmith P.C.; Ellerby L.M.; Ellerby H.M.; Bredesen D.E.; Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett 2002,514(2-3),122-128","journal-title":"FEBS Lett"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrc3701","volume":"14","author":"Lee A.S.","year":"2014","unstructured":"Lee A.S.; Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential. Nat Rev Cancer 2014,14(4),263-276","journal-title":"Nat Rev Cancer"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.3390\/cancers11111787","volume":"11","author":"Ge R.","year":"2019","unstructured":"Ge R.; Kao C.; Cell surface GRP78 as a death receptor and an anticancer drug target. Cancers 2019,11(11),1787","journal-title":"Cancers"},{"key":"ref=111","author":"Rangel HR","year":"2020","unstructured":"Rangel HR; Ortega JT; Maksoud S; Pujol FH; Serrano ML;  Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19 The COVID-19 resource centre is hosted on Elsevier connect, the company\u2019s public news and information 2020","journal-title":"Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19 The COVID-19 resource centre is hosted on Elsevier connect, the company\u2019s public news and information"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.lfs.2019.04.022","volume":"226","author":"Ibrahim I.M.","year":"2019","unstructured":"Ibrahim I.M.; Abdelmalek D.H.; Elfiky A.A.; GRP78: A cell\u2019s response to stress. Life Sci 2019,226,156-163","journal-title":"Life Sci"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jinf.2020.02.026","volume":"80","author":"Ibrahim I.M.","year":"2020","unstructured":"Ibrahim I.M.; Abdelmalek D.H.; Elshahat M.E.; Elfiky A.A.; COVID-19 spike-host cell receptor GRP78 binding site prediction. J Infect 2020,80(5),554-562","journal-title":"J Infect"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"2021.01.20.427368","DOI":"10.1101\/2021.01.20.427368","author":"Carlos A.J.","year":"2021","unstructured":"Carlos A.J.; Ha D.P.; Yeh D-W.; Van Krieken R.; Gill P.; Machida K.; GRP78 binds SARS-CoV-2 spike protein and ACE2 and GRP78 depleting antibody blocks viral entry and infection in vitro. BioRxiv 2021,2021.01.20.427368","journal-title":"BioRxiv"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41422-020-00460-y","volume":"31","author":"Wang S.","year":"2021","unstructured":"Wang S.; Qiu Z.; Hou Y.; Deng X.; Xu W.; Zheng T.; Wu P.; Xie S.; Bian W.; Zhang C.; Sun Z.; Liu K.; Shan C.; Lin A.; Jiang S.; Xie Y.; Zhou Q.; Lu L.; Huang J.; Li X.; AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cell Res 2021,31(2),126-140","journal-title":"Cell Res"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.matbio.2013.10.004","volume":"35","author":"Christianson H.C.","year":"2014","unstructured":"Christianson H.C.; Belting M.; Heparan sulfate proteoglycan as a cell-surface endocytosis receptor. Matrix Biol 2014,35,51-55","journal-title":"Matrix Biol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","volume":"183","author":"Clausen T.M.","year":"2020","unstructured":"Clausen T.M.; Sandoval D.R.; Spliid C.B.; Pihl J.; Perrett H.R.; Painter C.D.; Narayanan A.; Majowicz S.A.; Kwong E.M.; McVicar R.N.; Thacker B.E.; Glass C.A.; Yang Z.; Torres J.L.; Golden G.J.; Bartels P.L.; Porell R.N.; Garretson A.F.; Laubach L.; Feldman J.; Yin X.; Pu Y.; Hauser B.M.; Caradonna T.M.; Kellman B.P.; Martino C.; Gordts P.L.S.M.; Chanda S.K.; Schmidt A.G.; Godula K.; Leibel S.L.; Jose J.; Corbett K.D.; Ward A.B.; Carlin A.F.; Esko J.D.; SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2. Cell 2020,183(4),1043-1057.e15","journal-title":"Cell"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"41143","DOI":"10.1074\/jbc.M110.153791","volume":"285","author":"Smits N.C.","year":"2010","unstructured":"Smits N.C.; Kurup S.; Rops A.L.; ten Dam G.B.; Massuger L.F.; Hafmans T.; Turnbull J.E.; Spillmann D.; Li J.; Kennel S.J.; Wall J.S.; Shworak N.W.; Dekhuijzen P.N.R.; van der Vlag J.; van Kuppevelt T.H.; The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease. J Biol Chem 2010,285(52),41143-41151","journal-title":"J Biol Chem"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/cells9020273","volume":"9","author":"Zhou X.","year":"2020","unstructured":"Zhou X.; Yang G.; Guan F.; Biological functions and analytical strategies of sialic acids in tumor. Cells 2020,9(2),273","journal-title":"Cells"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"E8508","DOI":"10.1073\/pnas.1712592114","volume":"114","author":"Li W.","year":"2017","unstructured":"Li W.; Hulswit R.J.G.; Widjaja I.; Raj V.S.; McBride R.; Peng W.; Widagdo W.; Tortorici M.A.; van Dieren B.; Lang Y.; van Lent J.W.M.; Paulson J.C.; de Haan C.A.M.; de Groot R.J.; van Kuppeveld F.J.M.; Haagmans B.L.; Bosch B.J.; Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein. Proc Natl Acad Sci USA 2017,114(40),E8508-E8517","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41589-021-00924-1","volume":"18","author":"Nguyen L.","year":"2022","unstructured":"Nguyen L.; McCord K.A.; Bui D.T.; Bouwman K.M.; Kitova E.N.; Elaish M.; Kumawat D.; Daskhan G.C.; Tomris I.; Han L.; Chopra P.; Yang T.J.; Willows S.D.; Mason A.L.; Mahal L.K.; Lowary T.L.; West L.J.; Hsu S.T.D.; Hobman T.; Tompkins S.M.; Boons G.J.; de Vries R.P.; Macauley M.S.; Klassen J.S.; Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2. Nat Chem Biol 2022,18(1),81-90","journal-title":"Nat Chem Biol"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666221123111849","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/211151\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666221123111849","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T04:13:25Z","timestamp":1691727205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/211151\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":121,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612829666221123111849","relation":{},"ISSN":["1381-6128"],"issn-type":[{"type":"print","value":"1381-6128"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-05-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}